Impressively, TXL could inhibit the stroke‐enhanced expression of adhesion molecules (P‐selectin and ICAM‐1) and chemokines (CCL‐3, CCL‐4, CCL‐5, and CXCL1). The gene discussed is ICAM1; the disease is stroke disorder.